Skip to content
10-K

Annual Report

PHARMAGREEN BIOTECH INC. PHBI

0001477932-21-009538

← back to feed
Filed
Dec 29, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Dec 24, 2021 385.17M sh
Cash And Equivalents FY 2021 · Sep 30, 2021 $25.3K
Cash And Equivalents FY 2021 · Sep 30, 2020 $12.2K
Cash And Equivalents FY 2021 · Sep 30, 2019 $62.68K
Shares Diluted FY 2021 · Sep 30, 2020 388.37M sh
Operating Cash Flow FY 2021 · Sep 30, 2020 −$607.63K
Current Liabilities FY 2021 · Sep 30, 2020 $3.17M
Total Liabilities FY 2021 · Sep 30, 2020 $3.2M
Total Assets FY 2021 · Sep 30, 2020 $266.25K
Sga Expense FY 2021 · Sep 30, 2020 $63.71K
Net Income restated FY 2021 · Sep 30, 2020 −$2.48M
Operating Income FY 2021 · Sep 30, 2020 −$485.76K
Stockholders Equity restated FY 2021 · Sep 30, 2019 −$834.5K